erythrosine has been researched along with Syncope in 4 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coscas, G | 1 |
| Binaghi, M | 1 |
| Quentel, G | 1 |
| Yannuzzi, LA | 2 |
| Rohrer, KT | 1 |
| Tindel, LJ | 1 |
| Sobel, RS | 1 |
| Costanza, MA | 1 |
| Shields, W | 1 |
| Zang, E | 1 |
| Justice, J | 1 |
| Baldwin, HA | 1 |
| Chazan, BI | 1 |
| Balodimos, MC | 1 |
| Koncz, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Macular Perfusion Changes in Proliferative Diabetic Retinopathy Following Anti-VEGF Therapy Versus Targeted and Pan-retinal Photocoagulation Using Optical Coherence Tomography Angiography[NCT04674254] | Phase 4 | 43 participants (Actual) | Interventional | 2021-03-30 | Active, not recruiting | ||
| Evaluation of the Effect of Repeated Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using Optical Coherence Tomography Angiography[NCT03246152] | Phase 4 | 31 participants (Actual) | Interventional | 2017-10-23 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Correlation of BCVA change with degree of capillary non-perfusion before and after injections (NCT03246152)
Timeframe: At baseline and after 3-6 consecutive monthly injections.
| Intervention | Logmar (Mean) |
|---|---|
| Bevacizumab Group | -0.21 |
Effect of repeated intravitreal Anti-VEGF injections on Foveal Avascular Zone (FAZ) area measured using the freehand tool of ImageJ (NCT03246152)
Timeframe: At baseline and after 3-6 consecutive monthly injections.
| Intervention | mm^2 (Mean) |
|---|---|
| Bevacizumab Group | 0.03 |
Effect of repeated intravitreal Anti-VEGF injections on macular capillary density using the change in the skeletonized vascular density and fractal dimension measured by ImageJ (NCT03246152)
Timeframe: At baseline and after 3-6 consecutive monthly injections.
| Intervention | percentage of vascularity (Mean) |
|---|---|
| Bevacizumab Group | -2.5 |
2 reviews available for erythrosine and Syncope
| Article | Year |
|---|---|
[Incidents and accidents in fluorescence angiography].
Topics: Brain Diseases; Cardiomyopathies; Fluorescein Angiography; Fluoresceins; Humans; Hypersensitivity; N | 1982 |
Fluorescein angiography complication survey.
Topics: Fluorescein; Fluorescein Angiography; Fluoresceins; Health Surveys; Heart Diseases; Humans; Nausea; | 1986 |
Fluorescein angiography complication survey.
Topics: Fluorescein; Fluorescein Angiography; Fluoresceins; Health Surveys; Heart Diseases; Humans; Nausea; | 1986 |
Fluorescein angiography complication survey.
Topics: Fluorescein; Fluorescein Angiography; Fluoresceins; Health Surveys; Heart Diseases; Humans; Nausea; | 1986 |
Fluorescein angiography complication survey.
Topics: Fluorescein; Fluorescein Angiography; Fluoresceins; Health Surveys; Heart Diseases; Humans; Nausea; | 1986 |
1 trial available for erythrosine and Syncope
| Article | Year |
|---|---|
Effective differences in the formulation of intravenous fluorescein and related side effects.
Topics: Bicarbonates; Chromatography, Thin Layer; Clinical Trials as Topic; Drug Hypersensitivity; Fluoresce | 1974 |
1 other study available for erythrosine and Syncope
| Article | Year |
|---|---|
Untoward effects of fluorescein retinal angiography in diabetic patients.
Topics: Adult; Angioedema; Blood Gas Analysis; Blood Glucose; Blood Pressure; Chlordiazepoxide; Conjunctiva; | 1971 |